Cell-Integral-Diversity Criterion: A Proposal for Minimizing Cluster Artifact in Cell-Based Selections. - Obdulia Rabal; Rosalia Pascual; José I. Borrell; Jordi Teixidó (J. Chem. Inf. Model., 2007)

Comparison of Ligand-Based and Receptor-Based Virtual Screening of HIV Entry Inhibitors for the CXCR4 and CCR5 Receptors Using 3D Ligand Shape Matching and Ligand-Receptor Docking. - Violeta I. Pérez-Nueno; David W. Ritchie; Obdulia Rabal; Rosalia Pascual; José I. Borrell; Jordi Teixidó (J. Chem. Inf. Model., 2008)

APIF: A New Interaction Fingerprint Based on Atom Pairs and Its Application to Virtual Screening. - Violeta I. Pérez-Nueno; Obdulia Rabal; José I. Borrell; Jordi Teixidó (J. Chem. Inf. Model., 2009)

Using Novel Descriptor Accounting for Ligand-Receptor Interactions To Define and Visually Explore Biologically Relevant Chemical Space. - Obdulia Rabal; Julen Oyarzabal (J. Chem. Inf. Model., 2012)

Biologically Relevant Chemical Space Navigator: From Patent and Structure-Activity Relationship Analysis to Library Acquisition and Design. - Obdulia Rabal; Julen Oyarzabal (J. Chem. Inf. Model., 2012)

CHEMDNER: The drugs and chemical names extraction challenge. - Martin Krallinger; Florian Leitner; Obdulia Rabal; Miguel Vazquez; Julen Oyarzabal; Alfonso Valencia (J. Cheminformatics, 2015)

The CHEMDNER corpus of chemicals and drugs and its annotation principles. - Martin Krallinger; Obdulia Rabal; Florian Leitner; Miguel Vazquez; David Salgado; Zhiyong Lu; Robert Leaman; Yanan Lu; Donghong Ji; Daniel M. Lowe; Roger A. Sayle; Riza Theresa Batista-Navarro; et al. (J. Cheminformatics, 2015)

Novel Scaffold Fingerprint (SFP): Applications in Scaffold Hopping and Scaffold-Based Selection of Diverse Compounds. - Obdulia Rabal; Fares Ibrahim Amr; Julen Oyarzabal (J. Chem. Inf. Model., 2015)

The Markyt visualisation, prediction and benchmark platform for chemical and gene entity recognition at BioCreative/CHEMDNER challenge. - Martín Pérez-Pérez; Gael Pérez Rodríguez; Obdulia Rabal; Miguel Vazquez; Julen Oyarzabal; Florentino Fdez-Riverola; Alfonso Valencia; Martin Krallinger; Anália Lourenço (Database J. Biol. Databases Curation, 2016)

LimTox: a web tool for applied text mining of adverse event and toxicity associations of compounds, drugs and genes. - Andrés Cañada; Salvador Capella-Gutiérrez; Obdulia Rabal; Julen Oyarzabal; Alfonso Valencia; Martin Krallinger (Nucleic Acids Res., 2017)

Novel pharmacological maps of protein lysine methyltransferases: key for target deorphanization. - Obdulia Rabal; Andrea Castellar; Julen Oyarzabal (J. Cheminformatics, 2018)

Development and Validation of Molecular Overlays Derived from Three-Dimensional Hydrophobic Similarity with PharmScreen. - Javier Vázquez; Alessandro Deplano; Albert Herrero; Tiziana Ginex; Enric Gibert; Obdulia Rabal; Julen Oyarzabal; Enric Herrero; F. Javier Luque (J. Chem. Inf. Model., 2018)

PharmaCoNER: Pharmacological Substances, Compounds and proteins Named Entity Recognition track. - Aitor Gonzalez-Agirre; Montserrat Marimon; Ander Intxaurrondo; Obdulia Rabal; Marta Villegas; Martin Krallinger (BioNLP-OST@EMNLP-IJNCLP, 2019)

Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach. - Edgar López-López; Obdulia Rabal; Julen Oyarzabal; José L. Medina-Franco (J. Comput. Aided Mol. Des., 2020)

Fine tuning for success in structure-based virtual screening. - Emilie Pihan; Martin Kotev; Obdulia Rabal; Claudia Beato; Constantino Diaz Gonzalez (J. Comput. Aided Mol. Des., 2021)